Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

PTTG1 Levels Are Predictive of Saracatinib Sensitivity in Ovarian Cancer Cell Lines.

Nakachi I, Helfrich BA, Spillman MA, Mickler EA, Olson CJ, Rice JL, Coldren CD, Heasley LE, Geraci MW, Stearman RS.

Clin Transl Sci. 2016 Dec;9(6):293-301. doi: 10.1111/cts.12413. Epub 2016 Oct 20.

2.

Transcriptional Impact of Rare and Private Copy Number Variants in Hypoplastic Left Heart Syndrome.

Glidewell SC, Miyamoto SD, Grossfeld PD, Clouthier DE, Coldren CD, Stearman RS, Geraci MW.

Clin Transl Sci. 2015 Dec;8(6):682-9. doi: 10.1111/cts.12340. Epub 2015 Nov 4.

3.

Relationship between gene expression and lung function in Idiopathic Interstitial Pneumonias.

Steele MP, Luna LG, Coldren CD, Murphy E, Hennessy CE, Heinz D, Evans CM, Groshong S, Cool C, Cosgrove GP, Brown KK, Fingerlin TE, Schwarz MI, Schwartz DA, Yang IV.

BMC Genomics. 2015 Oct 26;16:869. doi: 10.1186/s12864-015-2102-3.

4.

Application of SNP microarrays to the genome-wide analysis of chromosomal instability in premalignant airway lesions.

Nakachi I, Rice JL, Coldren CD, Edwards MG, Stearman RS, Glidewell SC, Varella-Garcia M, Franklin WA, Keith RL, Lewis MT, Gao B, Merrick DT, Miller YE, Geraci MW.

Cancer Prev Res (Phila). 2014 Feb;7(2):255-65. doi: 10.1158/1940-6207.CAPR-12-0485. Epub 2013 Dec 17.

5.

Integrative omics approach identifies interleukin-16 as a biomarker of emphysema.

Bowler RP, Bahr TM, Hughes G, Lutz S, Kim YI, Coldren CD, Reisdorph N, Kechris KJ.

OMICS. 2013 Dec;17(12):619-26. doi: 10.1089/omi.2013.0038. Epub 2013 Oct 19.

6.

Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis.

Yang IV, Coldren CD, Leach SM, Seibold MA, Murphy E, Lin J, Rosen R, Neidermyer AJ, McKean DF, Groshong SD, Cool C, Cosgrove GP, Lynch DA, Brown KK, Schwarz MI, Fingerlin TE, Schwartz DA.

Thorax. 2013 Dec;68(12):1114-21. doi: 10.1136/thoraxjnl-2012-202943. Epub 2013 Jun 19.

PMID:
23783374
7.

Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease.

Bahr TM, Hughes GJ, Armstrong M, Reisdorph R, Coldren CD, Edwards MG, Schnell C, Kedl R, LaFlamme DJ, Reisdorph N, Kechris KJ, Bowler RP.

Am J Respir Cell Mol Biol. 2013 Aug;49(2):316-23. doi: 10.1165/rcmb.2012-0230OC.

8.

Endobronchial miRNAs as biomarkers in lung cancer chemoprevention.

Mascaux C, Feser WJ, Lewis MT, Barón AE, Coldren CD, Merrick DT, Kennedy TC, Eckelberger JI, Rozeboom LM, Franklin WA, Minna JD, Bunn PA, Miller YE, Keith RL, Hirsch FR.

Cancer Prev Res (Phila). 2013 Feb;6(2):100-8. doi: 10.1158/1940-6207.CAPR-12-0382. Epub 2012 Dec 26.

9.

Progressive endobronchial premalignancy: marked by original CIN.

Coldren CD, Miller YE.

Am J Respir Crit Care Med. 2011 Oct 15;184(8):869-70. doi: 10.1164/rccm.201108-1476ED. No abstract available.

10.

Bacteria-specific neutrophil dysfunction associated with interferon-stimulated gene expression in the acute respiratory distress syndrome.

Malcolm KC, Kret JE, Young RL, Poch KR, Caceres SM, Douglas IS, Coldren CD, Burnham EL, Moss M, Nick JA.

PLoS One. 2011;6(7):e21958. doi: 10.1371/journal.pone.0021958. Epub 2011 Jul 6.

11.

ZEB1-responsive genes in non-small cell lung cancer.

Gemmill RM, Roche J, Potiron VA, Nasarre P, Mitas M, Coldren CD, Helfrich BA, Garrett-Mayer E, Bunn PA, Drabkin HA.

Cancer Lett. 2011 Jan 1;300(1):66-78. doi: 10.1016/j.canlet.2010.09.007. Epub 2010 Oct 25.

12.

Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertension.

Risbano MG, Meadows CA, Coldren CD, Jenkins TJ, Edwards MG, Collier D, Huber W, Mack DG, Fontenot AP, Geraci MW, Bull TM.

Clin Transl Sci. 2010 Oct;3(5):210-8. doi: 10.1111/j.1752-8062.2010.00218.x. Erratum in: Clin Transl Sci. 2010 Dec;3(6):340. Hunt, James [added].

13.

Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension.

Aldred MA, Comhair SA, Varella-Garcia M, Asosingh K, Xu W, Noon GP, Thistlethwaite PA, Tuder RM, Erzurum SC, Geraci MW, Coldren CD.

Am J Respir Crit Care Med. 2010 Nov 1;182(9):1153-60. doi: 10.1164/rccm.201003-0491OC. Epub 2010 Jun 25.

14.

Development of an integrated genomic classifier for a novel agent in colorectal cancer: approach to individualized therapy in early development.

Pitts TM, Tan AC, Kulikowski GN, Tentler JJ, Brown AM, Flanigan SA, Leong S, Coldren CD, Hirsch FR, Varella-Garcia M, Korch C, Eckhardt SG.

Clin Cancer Res. 2010 Jun 15;16(12):3193-204. doi: 10.1158/1078-0432.CCR-09-3191. Epub 2010 Jun 8.

15.

Preclinical efficacy of a carboxylesterase 2-activated prodrug of doxazolidine.

Barthel BL, Zhang Z, Rudnicki DL, Coldren CD, Polinkovsky M, Sun H, Koch GG, Chan DC, Koch TH.

J Med Chem. 2009 Dec 10;52(23):7678-88. doi: 10.1021/jm900694z.

16.

Randomization in laboratory procedure is key to obtaining reproducible microarray results.

Yang H, Harrington CA, Vartanian K, Coldren CD, Hall R, Churchill GA.

PLoS One. 2008;3(11):e3724. doi: 10.1371/journal.pone.0003724. Epub 2008 Nov 14.

17.

Chromosomal microarray mapping suggests a role for BSX and Neurogranin in neurocognitive and behavioral defects in the 11q terminal deletion disorder (Jacobsen syndrome).

Coldren CD, Lai Z, Shragg P, Rossi E, Glidewell SC, Zuffardi O, Mattina T, Ivy DD, Curfs LM, Mattson SN, Riley EP, Treier M, Grossfeld PD.

Neurogenetics. 2009 Apr;10(2):89-95. doi: 10.1007/s10048-008-0157-x. Epub 2008 Oct 15.

18.

Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells.

Marek L, Ware KE, Fritzsche A, Hercule P, Helton WR, Smith JE, McDermott LA, Coldren CD, Nemenoff RA, Merrick DT, Helfrich BA, Bunn PA Jr, Heasley LE.

Mol Pharmacol. 2009 Jan;75(1):196-207. doi: 10.1124/mol.108.049544. Epub 2008 Oct 10.

19.

Circulating RNA transcripts identify therapeutic response in cystic fibrosis lung disease.

Saavedra MT, Hughes GJ, Sanders LA, Carr M, Rodman DM, Coldren CD, Geraci MW, Sagel SD, Accurso FJ, West J, Nick JA.

Am J Respir Crit Care Med. 2008 Nov 1;178(9):929-38. doi: 10.1164/rccm.200803-387OC. Epub 2008 Aug 21.

20.

Human herpesvirus-8 infection of primary pulmonary microvascular endothelial cells.

Bull TM, Meadows CA, Coldren CD, Moore M, Sotto-Santiago SM, Nana-Sinkam SP, Campbell TB, Geraci MW.

Am J Respir Cell Mol Biol. 2008 Dec;39(6):706-16. doi: 10.1165/rcmb.2007-0368OC. Epub 2008 Jun 27.

21.

Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma.

Frederick BA, Helfrich BA, Coldren CD, Zheng D, Chan D, Bunn PA Jr, Raben D.

Mol Cancer Ther. 2007 Jun;6(6):1683-91. Epub 2007 May 31.

22.

Gene expression profiling in pulmonary hypertension.

Bull TM, Coldren CD, Geraci MW, Voelkel NF.

Proc Am Thorac Soc. 2007 Jan;4(1):117-20. Review.

PMID:
17202300
23.

Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines.

Coldren CD, Helfrich BA, Witta SE, Sugita M, Lapadat R, Zeng C, Barón A, Franklin WA, Hirsch FR, Geraci MW, Bunn PA Jr.

Mol Cancer Res. 2006 Aug;4(8):521-8.

24.

Functional and genomic changes induced by alveolar transmigration in human neutrophils.

Coldren CD, Nick JA, Poch KR, Woolum MD, Fouty BW, O'Brien JM, Gruber MP, Zamora MR, Svetkauskaite D, Richter DA, He Q, Park JS, Overdier KH, Abraham E, Geraci MW.

Am J Physiol Lung Cell Mol Physiol. 2006 Dec;291(6):L1267-76. Epub 2006 Jul 21.

25.

Human lung project: evaluating variance of gene expression in the human lung.

Gruber MP, Coldren CD, Woolum MD, Cosgrove GP, Zeng C, Barón AE, Moore MD, Cool CD, Worthen GS, Brown KK, Geraci MW.

Am J Respir Cell Mol Biol. 2006 Jul;35(1):65-71. Epub 2006 Feb 23.

26.

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

Witta SE, Gemmill RM, Hirsch FR, Coldren CD, Hedman K, Ravdel L, Helfrich B, Dziadziuszko R, Chan DC, Sugita M, Chan Z, Baron A, Franklin W, Drabkin HA, Girard L, Gazdar AF, Minna JD, Bunn PA Jr.

Cancer Res. 2006 Jan 15;66(2):944-50.

27.

Microarray analysis of peripheral blood cells in pulmonary arterial hypertension, surrogate to biopsy.

Bull TM, Coldren CD, Nana-Sinkam P, Sotto-Santiago SM, Moore M, Voelkel NF, Geraci MW.

Chest. 2005 Dec;128(6 Suppl):584S. No abstract available.

PMID:
16373849
28.

Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis.

Nick JA, Coldren CD, Geraci MW, Poch KR, Fouty BW, O'Brien J, Gruber M, Zarini S, Murphy RC, Kuhn K, Richter D, Kast KR, Abraham E.

Blood. 2004 Dec 15;104(13):3878-85. Epub 2004 Aug 31. Erratum in: Blood. 2005 May 15;105(10):3785.

29.

Emphysema lung tissue gene expression profiling.

Golpon HA, Coldren CD, Zamora MR, Cosgrove GP, Moore MD, Tuder RM, Geraci MW, Voelkel NF.

Am J Respir Cell Mol Biol. 2004 Dec;31(6):595-600. Epub 2004 Jul 29.

PMID:
15284076
30.

Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension.

Bull TM, Coldren CD, Moore M, Sotto-Santiago SM, Pham DV, Nana-Sinkam SP, Voelkel NF, Geraci MW.

Am J Respir Crit Care Med. 2004 Oct 15;170(8):911-9. Epub 2004 Jun 23.

PMID:
15215156
31.

Gene expression changes in the human fibroblast induced by Centella asiatica triterpenoids.

Coldren CD, Hashim P, Ali JM, Oh SK, Sinskey AJ, Rha C.

Planta Med. 2003 Aug;69(8):725-32.

PMID:
14531023
32.
33.

The rational design and construction of a cuboidal iron-sulfur protein.

Coldren CD, Hellinga HW, Caradonna JP.

Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6635-40.

Supplemental Content

Loading ...
Support Center